Oxyntic gland neoplasm of the stomach: expanding the spectrum and proposal of terminology.


Journal

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605

Informations de publication

Date de publication:
02 2020
Historique:
received: 14 11 2018
accepted: 10 07 2019
revised: 06 07 2019
pubmed: 4 8 2019
medline: 26 1 2021
entrez: 4 8 2019
Statut: ppublish

Résumé

Gastric neoplasms exhibiting oxyntic gland differentiation typically are composed of cells with mild cytonuclear atypia differentiating to chief cells and to a lesser extent, parietal cells. Such tumors with atypical features have been reported also and terminology for this entity remains a matter of considerable debate. We analyzed and classified 26 tumors as oxyntic gland neoplasms within mucosa (group A, eight tumors) and with submucosal invasion. The latter was divided further into those with typical histologic features (group B, 14 tumors) and atypical features, including high-grade nuclear or architectural abnormality and presence of atypical cellular differentiation (group C, four tumors). Groups A and B tumors shared similar histologic features displaying either a chief cell predominant pattern characterized by monotonous chief cell proliferation, or a well-differentiated mixed cell pattern showing admixture of chief and parietal cells resembling fundic gland. In addition, group C tumors displayed atypical cellular differentiation, including mucous neck cell and foveolar epithelium. Moderate or even marked cytological atypia was noted in group C, whereas it was usually mild in the other groups except for three group B tumors with focal moderate atypia. More than 1000 μm submucosal invasion and lymphovascular invasions were recognized only in group C. Mutation analyses identified KRAS mutation in one group C tumor as well as GNAS mutation in in one group A and group B tumors. Intramucosal tumors appear to behave biologically benign and should be classified as "oxyntic gland adenoma". Those with submucosal invasion also have low malignant potential; however, a subset will have atypical features associated with aggressive histologic features and should be designated as "adenocarcinoma of fundic gland type". Especially, we suggest "adenocarcinoma of fundic gland mucosa type" for tumors with submucosal invasion exhibiting atypical cellular differentiation, because the feature is likely to be a sign of aggressive phenotype.

Identifiants

pubmed: 31375767
doi: 10.1038/s41379-019-0338-1
pii: S0893-3952(22)00925-5
doi:

Substances chimiques

Biomarkers, Tumor 0
Chromogranins 0
KRAS protein, human 0
GNAS protein, human EC 3.6.1.-
GTP-Binding Protein alpha Subunits, Gs EC 3.6.5.1
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

206-216

Références

Tsukamoto T, Yokoi T, Maruta S, Kitamura M, Yamamoto T, Ban H, et al. Gastric adenocarcinoma with chief cell differentiation. Pathol Int. 2007;57:517–22.
doi: 10.1111/j.1440-1827.2007.02134.x
Ueyama H, Yao T, Nakashima Y, Hirakawa K, Oshiro Y, Hirahashi M, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol. 2010;34:609–19.
doi: 10.1097/PAS.0b013e3181d94d53
Singhi AD, Lazenby AJ, Montgomery EA. Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp/adenoma. Am J Surg Pathol. 2012;36:1030–5.
doi: 10.1097/PAS.0b013e31825033e7
Ueo T, Yonemasu H, Ishida T. Gastric adenocarcinoma of fundic gland type with unusual behavior. Dig Endosc. 2014;26:293–4.
doi: 10.1111/den.12212
Bosman FT, World Health Organization., International Agency for Research on Cancer. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer; 2010.
Benedict MA, Lauwers GY, Jain D. Gastric adenocarcinoma of the fundic gland type: update and literature review. Am J Clin Pathol. 2018;149:461–73.
doi: 10.1093/ajcp/aqy019
Mitsui T, Niimi K, Yamashita H, Goto O, Aikou S, Hatao F, et al. Non-exposed endoscopic wall-inversion surgery as a novel partial gastrectomy technique. Gastric Cancer. 2014;17:594–9.
doi: 10.1007/s10120-013-0291-5
Chan K, Brown IS, Kyle T, Lauwers GY, Kumarasinghe MP. Chief cell-predominant gastric polyps: a series of 12 cases with literature review. Histopathology. 2016;68:825–33.
doi: 10.1111/his.12859
Sato Y, Fujino T, Kasagawa A, Morita R, Ozawa SI, Matsuo Y, et al. Twelve-year natural history of a gastric adenocarcinoma of fundic gland type. Clin J Gastroenterol. 2016;9:345–51.
doi: 10.1007/s12328-016-0680-5
Abe T, Nagai T, Fukunaga J, Okawara H, Nakashima H, Syutou M, et al. Long-term follow-up of gastric adenocarcinoma with chief cell differentiation using upper gastrointestinal tract endoscopy. Intern Med. 2013;52:1585–8.
doi: 10.2169/internalmedicine.52.0361
Hidaka Y, Mitomi H, Saito T, Takahashi M, Lee SY, Matsumoto K, et al. Alteration in the Wnt/beta-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type. Hum Pathol. 2013;44:2438–48.
doi: 10.1016/j.humpath.2013.06.002
Kato M, Uraoka T, Isobe Y, Abe K, Hirata T, Takada Y, et al. A case of gastric adenocarcinoma of fundic gland type resected by combination of laparoscopic and endoscopic approaches to neoplasia with non-exposure technique (CLEAN-NET). Clin J Gastroenterol. 2015;8:393–9.
doi: 10.1007/s12328-015-0619-2
Ueo T, Yonemasu H, Ishida T, Iwaki K, Yao K, Yao T, et al. Advanced stage of gastric adenocarcinoma of fundic gland type with venous invasion in the subserosa, report of a case. Stomach Intest. 2015;50:1566–72.
Ueyama H, Matsumoto K, Nagahara A, Hayashi T, Yao T, Watanabe S. Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy. 2014;46:153–7.
doi: 10.1055/s-0034-1364955
Ueyama H, Yao T, Matsumoto K, Tanaka I, Komori H, Akazawa Y, et al. Establishment of endoscopic diagnosis for gastric adenocarcinoma of fundic gland type (chief cell predominant type) using magnifying endoscopy with narrow-band imaging. Stomach Intest. 2015;50:1533–47.
Takahashi K, Fujiya M, Ichihara S, Moriichi K, Okumura T. Inverted gastric adenocarcinoma of fundic gland mucosa type colliding with well differentiated adenocarcinoma: a case report. Med (Baltim). 2017;96:e7080.
doi: 10.1097/MD.0000000000007080
Uchida A, Ozawa M, Ueda Y, Murai Y, Nishimura Y, Ishimatsu H, et al. Gastric adenocarcinoma of fundic gland mucosa type localized in the submucosa: a case report. Med (Baltim). 2018;97:e12341.
doi: 10.1097/MD.0000000000012341
Nomura R, Saito T, Mitomi H, Hidaka Y, Lee SY, Watanabe S, et al. GNAS mutation as an alternative mechanism of activation of the Wnt/beta-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type. Hum Pathol. 2014;45:2488–96.
doi: 10.1016/j.humpath.2014.08.016

Auteurs

Tetsuo Ushiku (T)

Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. usikut-tky@umin.ac.jp.

Akiko Kunita (A)

Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Ryohei Kuroda (R)

Department of Pathology, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.

Aya Shinozaki-Ushiku (A)

Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Sho Yamazawa (S)

Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yosuke Tsuji (Y)

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Mitsuhiro Fujishiro (M)

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Masashi Fukayama (M)

Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH